ASSESSMENT OF POTENTIAL COCAINE TREATMENT MEDICATIONS IN RODENTS 

NIH GUIDE, Volume 26, Number 11, April 4, 1997

 

RFP AVAILABLE:  N01DA-7-8076

 

P.T. 34



Keywords:

  Drugs/Drug Abuse 

  Chemotherapeutic Agents 

  Addiction 

 

National Institute on Drug Abuse

 

The National Institute on Drug Abuse (NIDA) is soliciting proposals

from qualified organizations having in-house capability to screen

compounds in the mouse locomotor activity and rat drug discrimination

paradigms for assessment as potential pharmacotherapies for cocaine

dependence.  Proprietary compounds will be evaluated in established

protocols, and the resulting data will be utilized by the Cocaine

Treatment Discovery Program of the NIDA Medications Development

Division.  Offerors must indicate possession of current DEA

registration for Schedule II-V substances prior to award and apply

for Schedule I registration at the time of award.  It is anticipated

that one (1) cost reimbursement, completion type contract will be

awarded for a period of four years, with possibilities for one option

year and other option quantities for additional followup studies.

 

RFP No. N01DA-7-8076 will be available electronically on or about

March 28, 1997, and may be accessed through the NIH Gopher and/or the

Internet by using the following electronic mail addresses and

instruction:

 

1.  NIH Home Page (via the World Wide Web): Access the NIH Home Page

by using http://www.nih.gov.  Once you are at the NIH Home Page,

select "Grants and Contracts"; select "NIH Gopher directory: listed

under the "Contracts Page" section.  Once at the NIH R&D Gopher,

select "RFPs Available"; select "NIDA"; and select "RFP N01DA-7-

8076".  (URL: gopher://gopher.nih.gov:70/11/res/rd-rfp)

 

2.  NIH Gopher: Point your Gopher client to GOPHER.NIH.GOV Port 70

(you should now be in the NIH Gopher).  Select "Grant and Research

Information"; select "R&D Request for Proposals (RFP)"; select "RFPs

Available"; select "NIDA"; and, select "RFP N01DA-7-8076".

 

Please note that the RFP for this acquisition will be streamlined to

include only the Work Statement, deliverable and reporting

requirements, special requirements and mandatory qualifications,

Technical Evaluation Criteria, and proposal preparation instructions.

All information required for the submission of an offer will be

contained in the electronic RFP package.

 

Response to this RFP will be due on or about May 12, 1997.  Any

responsible offeror may submit a proposal which will be considered by

the Government.  This advertisement does not commit the Government to

award a contract.

 

INQUIRIES

 

Kenneth E. Goodling

Contracts Management Branch

National Institute on Drug Abuse

5600 Fishers Lane, Room 10-49

Rockville, MD  20857

Telephone:  (301) 443-6677

FAX:  (301) 443-7595

Email:  kg25d@nih.gov

 

.


Return to 1997 Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.